$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein‐mediated stellate cell inactivation

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, v.16 no.14, 2002년, pp.1988 - 1990  

Wook Kang, Keon (National Research LaboratorySeoul National University Seoul Korea) ,  Gyoon Kim, Yoon (National Research LaboratorySeoul National University Seoul Korea) ,  Kyong Cho, Min (National Research LaboratorySeoul National University Seoul Korea) ,  Kyung Bae, Soo (College of Pharmacy and Research Institute of Pharmaceutical SciencesSeoul National University Seoul Korea) ,  Won Kim, Choon (Department of Clinical PathologyHanyang University Medical School Seoul Korea) ,  Gull Lee, Myung (National Research LaboratorySeoul National University Seoul Korea) ,  Geon Kim, Sang (National Research LaboratorySeoul National University Seoul Korea)

Abstract AI-Helper 아이콘AI-Helper

Liver cirrhosis (LC) is a chronic disease with high mortality rate. In the United States and Western world as well as Asian countries, LC is the major leading cause of death by disease. Yet, no effective therapeutic agent is available for LC treatment. Laboratory cirrhotic rats produced by dimethyln...

참고문헌 (61)

  1. National Institute on Alcohol Abuse and Alcoholism; Surveillance Report #41 DeBakey S. F. 1996 Liver cirrhosis mortality in the United States, 1970-1993 

  2. National Institute on Alcohol Abuse and Alcoholism; Surveillance Report #57 Yoon Y. 2001 Liver cirrhosis mortality in the United States, 1970-1998 

  3. Cancer Statistics in Japan 1999 Kakizoe T. 1999 

  4. Corpechot, Christophe, Carrat, Fabrice, Bonnand, Anne-Marie, Poupon, Renée Eugénie, Poupon, Raoul. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.32, no.6, 1196-1199.

  5. Parés, Albert, Caballería, Llorenç, Rodés, Juan, Bruguera, Miquel, Rodrigo, Luis, García-Plaza, Antonio, Berenguer, Joaquín, Rodríguez-Martínez, Dolores, Mercader, José, Velicia, Rosario. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.32, no.4, 561-566.

  6. Goulis, John, Leandro, Gioacchino, Burroughs, Andrew K. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. The Lancet, vol.354, no.9184, 1053-1060.

  7. Neuberger, James. Urso-panacea or placebo?. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.31, no.4, 1027-1028.

  8. Pares, A., Planas, R., Torres, M., Caballeria, J., Viver, J.M., Acero, D., Panes, J., Rigau, J., Santos, J., Rodes, J.. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.28, no.4, 615-621.

  9. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.34, no.2, 411-416.

  10. Ueki, Takahiro, Kaneda, Yasufumi, Tsutsui, Hiroko, Nakanishi, Kenji, Sawa, Yoshiki, Morishita, Ryuichi, Matsumoto, Kunio, Nakamura, Toshikazu, Takahashi, Hiroshi, Okamoto, Eizo, Fujimoto, Jiro. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature medicine, vol.5, no.2, 226-230.

  11. 10.1093/carcin/16.9.2159 

  12. Wattenberg, L W, Bueding, E. Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard.. Carcinogenesis, vol.7, no.8, 1379-1381.

  13. Ansher, Sherry S., Dolan, Patrick, Bueding, Ernest. Chemoprotective Effects of Two Dithiolthiones and of Butylhydroxyanisole Against Carbon Tetrachloride and Acetaminophen Toxicity. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.3, no.6, 932-935.

  14. Cancer Res Bolton M. G. 3499 53 1993 Transient intervention with oltipraz protects against aflatoxin‐induced hepatic tumorigenesis 

  15. Cancer Epidemiol. Biomarkers Prev Jacobson L. P. 257 6 1997 Oltipraz chemoprevention trial in Qidong, People's Republic of China: Study design and clinical outcomes 

  16. Wang, J.-S., Shen, X., He, X., Zhu, Y.-R., Zhang, B.-C., Wang, J.-B., Qian, G.-S., Kuang, S.-Y., Zarba, A., Egner, P. A., Jacobson, L. P., Munoz, A., Helzlsouer, K. J., Groopman, J. D., Kensler, T. W.. Protective Alterations in Phase 1 and 2 Metabolism of Aflatoxin B1 by Oltipraz in Residents of Qidong, People's Republic of China. Journal of the National Cancer Institute: JNCI, vol.91, no.4, 347-354.

  17. Cancer Res Kensler T. W. 4271 47 1987 Mechanism of protection against aflatoxin tumorigenicity in rats fed 5‐(2‐pyrazinyl)‐4‐methyl1, 2‐dithiol‐3‐thione (oltipraz) and related 1, 2‐dithiol‐3‐thiones and 1, 2‐dithiol‐3‐ones 

  18. Langouët, S, Mahéo, K, Berthou, F, Morel, F, Lagadic-Gossman, D, Glaise, D, Coles, B, Ketterer, B, Guillouzo, A. Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture.. Carcinogenesis, vol.18, no.7, 1343-1349.

  19. Albanis, Efsevia, Friedman, Scott L.. HEPATIC FIBROSIS. Clinics in liver disease, vol.5, no.2, 315-334.

  20. Yamazaki, H, Inui, Y, Yun, C H, Guengerich, F P, Shimada, T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.. Carcinogenesis, vol.13, no.10, 1789-1794.

  21. Yamazaki, H, Oda, Y, Funae, Y, Imaoka, S, Inui, Y, Guengerich, F P, Shimada, T. Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).. Carcinogenesis, vol.13, no.6, 979-985.

  22. Tsukamoto, H, Matsuoka, M, French, S W. Experimental models of hepatic fibrosis: a review.. Seminars in liver disease, vol.10, no.1, 56-65.

  23. Kang, Keon Wook, Choi, Sung Hee, Ha, Jong Ryul, Kim, Choon Won, Kim, Sang Geon. Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-β1 and tumor necrosis factor-α expression. Chemico-biological interactions, vol.139, no.1, 61-77.

  24. Flier, Jeffrey S., Underhill, Lisa H., Friedman, Scott L.. The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies. The New England journal of medicine, vol.328, no.25, 1828-1835.

  25. Qi, Zhe, Atsuchi, Nobuhiko, Ooshima, Akira, Takeshita, Akira, Ueno, Hikaru. Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proceedings of the National Academy of Sciences of the United States of America, vol.96, no.5, 2345-2349.

  26. A comparison of four connective tissue staining methods. Acta. Pathol. Microbiol. Immunol. Scand Vyberg M. 11 95 1987 Detection of early zone 3 liver fibrosis in chronic alcoholics 

  27. Anal. Quant. Cytol. Histol Moragas A. 169 20 1998 Characteristics of perisinusoidal collagenization in liver cirrhosis: Computer‐assisted quantitative analysis 

  28. Friedman, Scott L., Rockey, Don C., McGuire, Richard F., Maher, Jacquelyn J., Boyles, Janet K., Yamasaki, Glenn. Isolated hepatic lipocytes and kupffer cells from normal human liver: Morphological and functional characteristics in primary culture. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.15, no.2, 234-243.

  29. Voth, Daniel E., Heinzen, Robert A.. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cellular microbiology, vol.9, no.4, 829-840.

  30. Kim, Sang Geon, Nam, Seon Young, Kim, Choon Won, Kim, Jeong Hee, Cho, Chul Koo, Yoo, Seong Yul. Enhancement of Radiation-Inducible Hepatic Glutathione-S-TransferasesYa,Yb1,Yb2,Yc1, andYc2Gene Expression by Oltipraz: Possible Role in Radioprotection. Molecular pharmacology, vol.51, no.2, 225-233.

  31. Piette, J, Hirai, S, Yaniv, M. Constitutive synthesis of activator protein 1 transcription factor after viral transformation of mouse fibroblasts.. Proceedings of the National Academy of Sciences of the United States of America, vol.85, no.10, 3401-3405.

  32. Kang, Keon Wook, Ryu, Ji Hwa, Kim, Sang Geon. The Essential Role of Phosphatidylinositol 3-Kinase and of p38 Mitogen-Activated Protein Kinase Activation in the Antioxidant Response Element-Mediated rGSTA2 Induction by Decreased Glutathione in H4IIE Hepatoma Cells. Molecular pharmacology, vol.58, no.5, 1017-1025.

  33. Nancy, Vanessa, Wolthuis, Rob M.F., de Tand, Marie-France, Janoueix-Lerosey, Isabelle, Bos, Johannes L., de Gunzburg, Jean. Identification and Characterization of Potential Effector Molecules of the Ras-related GTPase Rap2. The Journal of biological chemistry, vol.274, no.13, 8737-8745.

  34. Wagner, Andreas H., Krzesz, Robert, Gao, Dingcheng, Schroeder, Christian, Cattaruzza, Marco, Hecker, Markus. Decoy Oligodeoxynucleotide Characterization of Transcription Factors Controlling Endothelin-B Receptor Expression in Vascular Smooth Muscle Cells. Molecular pharmacology, vol.58, no.6, 1333-1340.

  35. Henriksen, Jens H., Stage, Jens G., Schlichting, Poul, Winkler, Kjeld. Intraperitoneal pressure: ascitic fluid and splanchnic vascular pressures, and their role in prevention and formation of ascites. Scandinavian journal of clinical & laboratory investigation, vol.40, no.6, 493-501.

  36. Mathews, Michael B., Bernstein, Robert M., Franza Jr, B. Robert, Garrels, James I.. Identity of the proliferating cell nuclear antigen and cyclin. Nature, vol.309, no.5966, 374-376.

  37. Hautekeete, Marc L., Geerts, Albert. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Archiv : an international journal of pathology, vol.430, no.3, 195-207.

  38. Tsitologiia Kiiasov A.P. 876 40 1998 Contact inhibition of desmin expression in rat liver Ito cells in vitro 

  39. Krüse, Jacqueline J.C.M., Bart, Cindy I., Leer, Jan-Willem H., Wondergem, Jan. DETECTION AND QUANTITATIVE MEASUREMENT OF TRANSFORMING GROWTH FACTOR-β1 (TGF-β1) GENE EXPRESSION USING A SEMI-NESTED COMPETITIVE PCR ASSAY. Cytokine, vol.11, no.2, 179-185.

  40. Kidney Int Mizuno S. 937 57 2000 10.1038/sj.ki.4491416 Reciprocal balance of hepatocyte growth factor and transforming growth factor‐β1 in renal fibrosis in mice 

  41. GenBank access# AF249327 Yoon G. 2000 5'‐Flanking region of rat TGF‐β1 gene 

  42. LUO, JIING‐CHYUAN, HWANG, SHINN‐JANG, LAI, CHIUNG‐RU, LU, CHING‐LIANG, LI, CHUNG‐PIN, TSAY, SHYH‐HAW, WU, JAW‐CHING, CHANG, FULL‐YOUNG, LEE, SHOU‐DONG. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan. Journal of gastroenterology and hepatology, vol.13, no.7, 685-690.

  43. Am. J. Gastroenterol Matsuzaki Y. 15 85 1990 Improvement of biliary enzyme levels and itching as a result of long‐term administration of ursodeoxycholic acid in primary biliary cirrhosis 

  44. A preliminary report. J. Hepatol Nomura F. 65 11 1990 10.1016/0168-8278(90)90273-T Detection of malotilate toxicity in vitro with peripheral blood mononuclear cells as targets 

  45. Baroni, G., D'Ambrosio, L., Curto, P., Casini, A., Mancini, R., Jezequel, A., Benedetti, A.. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.23, no.5, 1189-1199.

  46. Pinzani, Massimo, Marra, Fabio, Carloni, Vinicio. Signal transduction in hepatic stellate cells. Liver, vol.18, no.1, 2-13.

  47. Tsukamoto, Hidekazu. Cytokine Regulation of Hepatic Stellate Cells in Liver Fibrosis. Alcoholism: clinical and experimental research, vol.23, no.5, 911-911.

  48. Skrtic, Stanko, Wallenius, Kristina, Sjögren, Klara, Isaksson, Olle G.P., Ohlsson, Claes, Jansson, John-Olov. Possible Roles of Insulin-Like Growth Factor in Regulation of Physiological and Pathophysiological Liver Growth. Hormone research, vol.55, no.suppl1, 1-6.

  49. Clouthier, D E, Comerford, S A, Hammer, R E. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.. The Journal of clinical investigation, vol.100, no.11, 2697-2713.

  50. George, Joseph, Chandrakasan, Gowri. Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochimica et biophysica acta, Protein structure and molecular enzymology, vol.1292, no.2, 215-222.

  51. J. Biol. Chem Inagaki Y. 276 2001 10.1074/jbc.M010485200 Interaction between GC box binding factors and Smad proteins modulates cell lineage‐specific alpha 2(I) collagen gene transcription 

  52. 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S 

  53. Iraburu, María J., Domínguez-Rosales, José A., Fontana, Luis, Auster, Anitra, García-Trevijano, Elena R., Covarrubias-Pinedo, Amador, Rivas-Estilla, Ana María, Greenwel, Patricia, Rojkind, Marcos. Tumor necrosis factorα down-regulates expression of theα1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPβ- and C/EBPδ-dependent mechanism. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.31, no.5, 1086-1093.

  54. Greenwel, Patricia, Tanaka, Shizuko, Penkov, Dmitri, Zhang, Wen, Olive, Michelle, Moll, Jonathan, Vinson, Charles, Di Liberto, Maurizio, Ramirez, Francesco. Tumor Necrosis Factor Alpha Inhibits Type I Collagen Synthesis through Repressive CCAAT/Enhancer-Binding Proteins. Molecular and cellular biology, vol.20, no.3, 912-918.

  55. J. Biol. Chem Zauberman A. 276 2001 10.1074/jbc.M005813200 Smad proteins suppress CCAAT/enhancerbinding protein (C/EBP)β‐ and STAT3‐mediated transcriptional activation of the haptoglobin promoter 

  56. Cancer Res Rao C. V. 2502 53 1993 Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats 

  57. Cell. Biochem Kensler T. W. 101 22 1995 10.1002/jcb.240590813 Oltipraz: Clinical opportunities for cancer chemoprevention, J 

  58. 10.1093/carcin/19.12.2133 

  59. Mol. Pharmacol Prochaska H. J. 15 48 1995 Inhibition of human immunodeficiency virus type 1 replication by 7‐methyl‐6, 8‐bis(methylthio)pyrrolo[1, 2a]pyrazine, an in vivo metabolite of oltipraz 

  60. Crowell, J.A., Page, J.G., Rodman, L.E., Heath, J.E., Goldenthal, E.I., Hall, L.B., Kelloff, G.J.. Chronic Toxicity Studies of 5-(2-Pyrazinyl)-4-methyl-1,2-dithiole- 3-thione, a Potential Chemopreventive Agent. Fundamental and applied toxicology : official journal of the Society of Toxicology, vol.35, no.1, 9-21.

  61. Ann. Trop. Med. Parasitol El Tayeb M. 53 82 1988 10.1080/00034983.1988.11812208 Praziquantel and oltipraz: The treatment of school children infected with Schistosoma mansoni and/or Schistosoma haematobium in Gezira, Sudan 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로